Commentary by Henry Tran, MD
Old adage: just because it’s new doesn’t necessarily mean it’s better. The FDA approved the usage of drug-eluting stents (DES) in 2003 and these stents were quickly embraced by …
Commentary by Henry Tran, MD
Old adage: just because it’s new doesn’t necessarily mean it’s better. The FDA approved the usage of drug-eluting stents (DES) in 2003 and these stents were quickly embraced by …
Commentary by Arthur Sinkman MD, NYU Department of Psychiatry
Three years ago the FDA began requiring that all selective serotonin reuptake inhibitors (SSRIs) carry a black-box warning stating that their use in children and adolescents is associated …
Case presentation by Minisha Sood MD, Chief Resident
Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the link below to review the case, followed by a slide presentation …
Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations
If you think the modern scientific literature is reading more and more like science fiction each day, get a load of this: apparently they are …
In this series, we are trying to cut through some of the media hype in order to summarize the health care proposals put forward by the leading candidates for President.
Commentary by Aaron Lord …
Commentary by Noga Chlamtac MD, PGY 3
This weeks grand rounds was delivered by Dr. Pramod Mistry, Professor of Pediatrics and Medicine, and Chief of the Section of Pediatric Gastroenterology, Hepatology and Nutrition at …
Commentary by Alana Choy-Shan MD, NYU Chief Resident
The highly anticipated results of the ENHANCE trial will likely be presented at the American College of Cardiology meeting in March, but the preliminary results already have everyone …
Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
Published in the NEJM this week was a study intended to conclusively determine whether corticosteroids are an effective adjunctive therapy in severe sepsis. Although corticosteroid …